Mercury General Corporation Announces Second Quarter Results and Declares Quarterly Dividend
LOS ANGELES, July 29, 2025 /PRNewswire/ -- Mercury General Corporation (NYSE: MCY) reported today for the second quarter of 2025: Consolidated...
Morning Movers
Select Water Solutions Announces Release of 2024 Sustainability Report
In 2024, Select treated or recycled 20.0 billion gallons of water, a 9% increase from 2023 while also increasing our...
LendingClub Reports Second Quarter 2025 Results
Grew Originations +32%, Revenue +33%, and Net Income +156% Compared to Prior Year Revenue growth combined with expense discipline delivers...
Aclaris Therapeutics Announces Positive Top-Line Results from Open-Label Phase 2a Trial of ATI-2138, a Potent and Selective Investigational Inhibitor of ITK and JAK3; Trial Achieves Primary and Key Secondary Endpoints
- Primary Endpoint Analysis Confirms Favorable Tolerability Profile of ATI-2138 Without Certain Risks Associated with Other Agents in the Class...
STAG INDUSTRIAL ANNOUNCES SECOND QUARTER 2025 RESULTS
BOSTON, July 29, 2025 /PRNewswire/ -- STAG Industrial, Inc. (the "Company") (NYSE:STAG), today announced its financial and operating results for...
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025
SALT LAKE CITY, July 29, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal...
Red Rock Resorts Announces Second Quarter 2025 Results
LAS VEGAS, July 29, 2025 /PRNewswire/ -- Red Rock Resorts, Inc. ("Red Rock Resorts," "we" or the "Company") (NASDAQ: RRR) today...
LendingClub Reports Second Quarter 2025 Results
Grew Originations +32%, Revenue +33%, and Net Income +156% Compared to Prior Year Revenue growth combined with expense discipline delivers...
Purple Innovation Reports Second Quarter 2025 Results; Reaffirms 2025 Guidance
Net Loss Exceeded Expectations; Adjusted EBITDA Margin Improved 120 Basis Points versus Last Year Strong Rejuvenate 2.0 Demand More than...
DIAMOND HILL INVESTMENT GROUP, INC. REPORTS RESULTS FOR SECOND QUARTER 2025 AND DECLARES QUARTERLY DIVIDEND
COLUMBUS, Ohio, July 29, 2025 /PRNewswire/ -- Diamond Hill Investment Group, Inc. (Nasdaq: DHIL) today reported unaudited financial results for...
Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)
– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm...
Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update
- Appointed Dr. Roger Sidhu as Chief Medical Officer - - Completed enrollment in randomized Phase 2 CRDF-004 trial evaluating...
Northwest Bancshares, Inc. Announces Second Quarter 2025 net income of $34 million, or $0.26 per diluted share
Total revenue grew 54% and net interest income increased 12% over prior year quarterSuccessful completion and systems conversion of Penns...
Exagen Inc. Reports Strong Q2 2025 Results
CARLSBAD, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today...
Anghami Announces 1-for-10 Reverse Stock Split
ABU DHABI, UAE, July 29, 2025 /PRNewswire/ -- Anghami Inc. (NASDAQ: ANGH) ("Anghami" or "the Company"), the leading multi-media streaming platform...
Expro Group Holdings N.V. Announces Second Quarter 2025 Results, Reaffirms Full-Year Guidance, and Remains Committed to Shareholder Return Targets
HOUSTON--(BUSINESS WIRE)--Expro Group Holdings N.V. (NYSE: XPRO) (the “Company” or “Expro”) today reported financial and operational results for the three...
Expro Group Holdings N.V. Announces Second Quarter 2025 Results, Reaffirms Full-Year Guidance, and Remains Committed to Shareholder Return Targets
HOUSTON--(BUSINESS WIRE)--Expro Group Holdings N.V. (NYSE: XPRO) (the “Company” or “Expro”) today reported financial and operational results for the three...
Camden National Corporation Reports Second Quarter 2025 Earnings
Net Income of $14.1 Million and Diluted EPS of $0.83 for the Second Quarter CAMDEN, Maine, July 29, 2025 /PRNewswire/...
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata
SAN FRANCISCO, July 29, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted...
Kyverna Therapeutics to Host Virtual KOL Event to Highlight Neuroimmunology CAR T Franchise
Webcast to be held August 28, 2025, 11:00am ET EMERYVILLE, Calif., July 29, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq:...
eHealth Announces CEO Succession
Derrick Duke Appointed Chief Executive Officer After Transition Period Fran Soistman to Retire, Remain on eHealth Board of Directors AUSTIN,...
Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End
Clear regulatory path and strong survival data in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) support accelerated strategy to drive shareholder...
NEXPOINT RESIDENTIAL TRUST, INC. REPORTS SECOND QUARTER 2025 RESULTS
NXRT Reports $100 million SOFR Swap and $7.6 million of Share Repurchase ActivityDALLAS, July 29, 2025 /PRNewswire/ -- NexPoint Residential...
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 29 – 30, 2025
WILMINGTON, Del., July 29, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), today announced that...
Alkermes plc Reports Second Quarter 2025 Financial Results
— Second Quarter Revenues of $390.7 Million — — GAAP Net Income of $87.1 Million and Diluted GAAP Earnings per...
AbbVie Submits for U.S. FDA Approval of Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
Combination therapy has potential to be an all-oral, fixed-duration regimen for previously untreated patients with CLL Application is supported by...
IQST – IQSTEL and ONAR – ONAR Join Forces to Disrupt Traditional Marketing with AI Agents
Latest Deployment of AIRWEB Underscores IQSTEL's Expansion into High-Tech, High-Margin Verticals — Driving Forward Its $1 Billion Revenue Strategy NEW...
Johnson Controls Reports Strong Q3 Results; Raises FY25 Guidance
Q3 sales increased 3% and organic sales increased 6%* Q3 GAAP EPS of $0.94; Q3 Adjusted EPS* of $1.05 Q3...
Hoth Therapeutics Announces Engagement with ICON and Expansion of Phase II Clinical Trial for HT-001 in Europe
The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union...
Shutterstock Reports Second Quarter 2025 Financial Results
NEW YORK, July 29, 2025 /PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK) (the "Company"), a leading global creative platform offering high-quality creative content...
Duke Energy announces sale of its Tennessee Piedmont Natural Gas business to Spire for $2.48 billion
Transaction expected to close Q1 2026 Proceeds help efficiently fund Duke Energy's $83 billion five-year capital plan CHARLOTTE, N.C., July...
Spire to acquire Tennessee Piedmont Natural Gas business from Duke Energy
ST. LOUIS, July 29, 2025 /PRNewswire/ -- Spire Inc. (NYSE: SR) today announced it has entered into an agreement with Piedmont Natural...
CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights
PRINCETON, N.J., July 29, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in...
B. Riley Financial to Host Call to Discuss Fiscal Year 2024 Results and a Preliminary Financial and Business Update for 1H2025 on Wednesday, August 13, 2025
LOS ANGELES, July 29, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("BRF" or the "Company"), a diversified financial services...
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma
SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage...
NAPCO Security Technologies CEO & Founder Richard Soloway Named 2025 Security Innovator
AMITYVILLE, N.Y., July 29, 2025 /PRNewswire/ -- NAPCO Security Technologies, Inc. (NASDAQ: NSSC), one of the leading designers and manufacturers...
Norfolk Southern reports second quarter 2025 results
Delivers net income and EPS growth of 4% and 5%, respectively; adjusted net income and EPS improved 7% and 8%,...
Atossa Therapeutics Announces Positive FDA Feedback, Advances Toward IND for (Z)-Endoxifen Clinical Program in ER+/HER2- Metastatic Breast Cancer
SEATTLE, July 29, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines in oncology,...
Powerfleet Sets First Quarter Fiscal 2026 Conference Call for Monday, August 11, 2025, at 8:30 a.m. ET
WOODCLIFF LAKE, N.J., July 29, 2025 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: AIOT) today announced that it will hold a conference call...
ROYAL CARIBBEAN GROUP REPORTS SECOND QUARTER RESULTS AND INCREASES FULL YEAR GUIDANCE
MIAMI, July 29, 2025 /PRNewswire/ -- Royal Caribbean Group (NYSE: RCL) today reported second quarter Earnings per Share ("EPS") of...